Testing for BRCA mutations linked to breast and ovarian cancers could become easier and more accessible with the help of artificial intelligence, potentially allowing earlier treatment. A partnership ...

A clustered family history of breast, ovarian, and colon cancers appropriately triggered germline testing, with BRCA1 mutation status informing individualized risk stratification and counseling.

Fanconi anaemia (FA) is an autosomal recessive disease that is characterized by developmental abnormalities, cancer susceptibility and cellular sensitivity to crosslinking agents. The seven cloned FA ...

Such BRCA nes s may occur as a result of epigenetic silencing of BRCA genes or inactivation of other HR-associated genes, including ATM, RAD51, or members of the FANC family of genes (Yap et al, 2011; ...

NEW YORK – The European Commission approved Johnson & Johnson's Akeega (niraparib/abiraterone acetate) in combination with androgen deprivation therapy (ADT) for patients with BRCA1/2-mutated ...